T1	PROC 14 25	tratamiento
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	DISO 58 87	hepatitis crónica por virus B
#2	AnnotatorNotes T2	C0524909; Hepatitis B, Chronic; Disease or Syndrome
T3	PROC 164 169	HBeAg
#3	AnnotatorNotes T3	C0201483; Hepatitis Be antigen measurement; Laboratory Procedure
T4	CHEM 203 213	lamivudina
#4	AnnotatorNotes T4	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T5	PROC 1103 1111	anti-HBe
#5	AnnotatorNotes T5	C0201484; Hepatitis Be antibody measurement; Laboratory Procedure (?)
T6	CHEM 325 332	fármaco
#6	AnnotatorNotes T6	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T7	DISO 401 430	hepatitis crónica por virus B
#7	AnnotatorNotes T7	C0524909; Hepatitis B, Chronic; Disease or Syndrome
T8	PROC 452 463	tratamiento
#8	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	Observation 1507 1541	modificaciones en la función renal
T10	PROC 1686 1694	anti-HBe
#10	AnnotatorNotes T10	C0201484; Hepatitis Be antibody measurement; Laboratory Procedure (?)
T11	PROC 661 666	HBeAg
#11	AnnotatorNotes T11	C0201483; Hepatitis Be antigen measurement; Laboratory Procedure
T12	PROC 681 686	HBeAg
#12	AnnotatorNotes T12	C0201483; Hepatitis Be antigen measurement; Laboratory Procedure
T13	PROC 722 733	tratamiento
#13	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	PROC 807 818	tratamiento
#14	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	CHEM 830 833	IFN
#15	AnnotatorNotes T15	C0021747; Interferons; Immunologic Factor · Amino Acid, Peptide, or Protein
T16	PROC 860 871	tratamiento
#16	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	CHEM 886 894	adefovir
#17	AnnotatorNotes T17	C0050175; adefovir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T18	PROC 947 952	HBsAg
#18	AnnotatorNotes T18	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T19	PROC 974 979	HBeAg
#19	AnnotatorNotes T19	C0201483; Hepatitis Be antigen measurement; Laboratory Procedure
T20	PROC 1038 1041	ADN
#20	AnnotatorNotes T20	C1262035; DNA antibody measurement; Laboratory Procedure
T21	PROC 1070 1075	HBeAg
#21	AnnotatorNotes T21	C0201483; Hepatitis Be antigen measurement; Laboratory Procedure
T22	PROC 1133 1138	HBeAg
#22	AnnotatorNotes T22	C0201483; Hepatitis Be antigen measurement; Laboratory Procedure
T23	PROC 1189 1192	ADN
#23	AnnotatorNotes T23	C1262035; DNA antibody measurement; Laboratory Procedure
T24	DISO 1218 1226	mutantes
#24	AnnotatorNotes T24	C0596988; Mutant; Cell or Molecular Dysfunction
T25	PROC 1276 1281	HBeAg
#25	AnnotatorNotes T25	C0201483; Hepatitis Be antigen measurement; Laboratory Procedure
T26	PROC 1348 1359	tratamiento
#26	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T27	PROC 1377 1391	niveles de ADN
#27	AnnotatorNotes T27	C1262035; DNA antibody measurement; Laboratory Procedure
T28	PROC 1465 1478	transaminasas
#28	AnnotatorNotes T28	C0919834; Transaminase Assay; Laboratory Procedure
T29	CHEM 1596 1606	lamivudina
#29	AnnotatorNotes T29	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T30	DISO 1764 1772	mutantes
#30	AnnotatorNotes T30	C0596988; Mutant; Cell or Molecular Dysfunction
T31	PROC 1806 1811	HBeAg
#31	AnnotatorNotes T31	C0201483; Hepatitis Be antigen measurement; Laboratory Procedure
T32	PROC 1926 1937	tratamiento
#32	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	PROC 190 198	tratados
#33	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	CHEM 30 40	lamivudina
#34	AnnotatorNotes T34	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T35	Observation 255 289	modificaciones en la función renal
T36	ANAT 284 289	renal
#36	AnnotatorNotes T36	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T37	CHEM 468 478	lamivudina
#37	AnnotatorNotes T37	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T38	CHEM 738 748	lamivudina
#38	AnnotatorNotes T38	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T39	CHEM 1232 1242	lamivudina
#39	AnnotatorNotes T39	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T40	ANAT 1536 1541	renal
#40	AnnotatorNotes T40	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T41	CHEM 1778 1788	lamivudina
#41	AnnotatorNotes T41	C0209738; lamivudine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T42	PROC 307 315	tratados
#42	AnnotatorNotes T42	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T43	PROC 343 376	Se estudió de forma retrospectiva
#43	AnnotatorNotes T43	C0035363; Retrospective Studies; Research Activity
T44	LIVB 44 53	pacientes
#44	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	Duration 68 75	crónica
#45	AnnotatorNotes T45	C0205191; chronic; Temporal Concept
T46	LIVB 80 87	virus B
#46	AnnotatorNotes T46	C0019378; Herpesvirus 1, Cercopithecine; Virus
T47	LIVB 154 163	pacientes
#47	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T49	LIVB 297 306	pacientes
#48	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	LIVB 387 396	pacientes
#49	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Duration 411 418	crónica
#50	AnnotatorNotes T51	C0205191; chronic; Temporal Concept
T52	LIVB 423 430	virus B
#51	AnnotatorNotes T52	C0019378; Herpesvirus 1, Cercopithecine; Virus
T53	Date 485 502	noviembre de 1999
T54	Date 505 518	marzo de 2004
T56	LIVB 629 638	pacientes
#52	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T58	Duration 756 766	23,7 meses
T59	LIVB 781 790	pacientes
#53	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Neg_cue 896 903	Ninguno
T61	LIVB 911 920	pacientes
#54	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	LIVB 964 973	pacientes
#55	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	Date 1005 1016	actualmente
T66	LIVB 1123 1132	pacientes
#56	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T68	LIVB 1266 1275	pacientes
#57	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T70	Duration 1363 1371	dos años
T71	LIVB 1392 1397	viral
#58	AnnotatorNotes T71	C0042776; Virus; Virus
T73	LIVB 1484 1493	pacientes
#59	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group
T74	Neg_cue 1494 1496	no
T75	LIVB 1581 1590	pacientes
#60	AnnotatorNotes T75	C0030705; Patients; Patient or Disabled Group
T77	LIVB 1796 1805	pacientes
#61	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T79	LIVB 1895 1904	pacientes
#62	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	Duration 1909 1922	más de un año
T82	PHYS 276 289	función renal
#63	AnnotatorNotes T82	C0232804; Renal function; Organ or Tissue Function
T48	Duration 768 772	3-46
T55	CHEM 1388 1391	ADN
#64	AnnotatorNotes T55	C0012854; DNA; Biologically Active Substance · Nucleic Acid, Nucleoside, or Nucleotide
T57	PHYS 1528 1541	función renal
#65	AnnotatorNotes T57	C0232804; Renal function; Organ or Tissue Function
A1	Assertion T61 Negated
A2	Assertion T9 Negated
A3	Status T14 History_of
A4	Status T15 History_of
T64	Observation 1 25	Respuesta al tratamiento
#66	AnnotatorNotes T64	C1319171; Medication response; Finding
R1	Causes Arg1:T34 Arg2:T64	
R2	Experiences Arg1:T44 Arg2:T64	
R3	Used_for Arg1:T34 Arg2:T1	
R4	Experiences Arg1:T44 Arg2:T1	
R5	Experiences Arg1:T44 Arg2:T2	
R6	Has_Duration_or_Interval Arg1:T2 Arg2:T45	
R7	Causes Arg1:T46 Arg2:T2	
T65	Observation 117 137	respuesta bioquímica
R10	Experiences Arg1:T47 Arg2:T65	
R11	Used_for Arg1:T4 Arg2:T33	
R12	Experiences Arg1:T47 Arg2:T33	
R13	Experiences Arg1:T47 Arg2:T3	
T67	Observation 117 126;140 150	respuesta virológica
#67	AnnotatorNotes T67	C4053862; Virologic Response; Finding
R8	Experiences Arg1:T47 Arg2:T67	
T69	Result_or_Value 170 178	positivo
R9	Has_Result_or_Value Arg1:T3 Arg2:T69	
T72	Result_or_Value 181 189	negativo
R14	Has_Result_or_Value Arg1:T3 Arg2:T72	
R15	Location_of Arg1:T36 Arg2:T82	
R16	Location_of Arg1:T36 Arg2:T35	
R17	Experiences Arg1:T49 Arg2:T35	
R18	Experiences Arg1:T49 Arg2:T42	
R19	Used_for Arg1:T6 Arg2:T42	
R20	Negation Arg1:T74 Arg2:T9	
R21	Location_of Arg1:T40 Arg2:T9	
R22	Experiences Arg1:T73 Arg2:T9	
R23	Before Arg1:T42 Arg2:T35	
R24	Experiences Arg1:T50 Arg2:T7	
R25	Has_Duration_or_Interval Arg1:T7 Arg2:T51	
R26	Causes Arg1:T52 Arg2:T7	
R27	Experiences Arg1:T50 Arg2:T8	
R28	Used_for Arg1:T37 Arg2:T8	
R29	After Arg1:T8 Arg2:T53	
R30	Before Arg1:T8 Arg2:T54	
R31	Experiences Arg1:T56 Arg2:T11	
R32	Experiences Arg1:T56 Arg2:T12	
T76	Result_or_Value 667 675	positivo
R33	Has_Result_or_Value Arg1:T11 Arg2:T76	
T78	Result_or_Value 687 695	negativo
R34	Has_Result_or_Value Arg1:T12 Arg2:T78	
R36	Has_Duration_or_Interval Arg1:T38 Arg2:T58	
R37	Has_Duration_or_Interval Arg1:T38 Arg2:T48	
R35	Used_for Arg1:T38 Arg2:T13	
R38	Experiences Arg1:T59 Arg2:T14	
R39	Used_for Arg1:T15 Arg2:T14	
R40	Used_for Arg1:T17 Arg2:T16	
R41	Negation Arg1:T60 Arg2:T61	
R42	Experiences Arg1:T61 Arg2:T18	
T81	Result_or_Value 933 943	negativizó
#9	AnnotatorNotes T81	C0205160; Negative; Finding
#35	AnnotatorNotes T78	C0205160; Negative; Finding
#68	AnnotatorNotes T72	C0205160; Negative; Finding
#69	AnnotatorNotes T69	C1446409; Positive; Finding
#70	AnnotatorNotes T76	C1446409; Positive; Finding
R47	Experiences Arg1:T62 Arg2:T19	
T83	Result_or_Value 980 988	positivo
#71	AnnotatorNotes T83	C1446409; Positive; Finding
R48	Experiences Arg1:T62 Arg2:T83	
R49	Has_Result_or_Value Arg1:T19 Arg2:T83	
T84	Result_or_Value 1054 1066	negativizado
#72	AnnotatorNotes T84	C0205160; Negative; Finding
R50	Experiences Arg1:T62 Arg2:T84	
R51	Experiences Arg1:T62 Arg2:T21	
T85	Neg_cue 1084 1087	sin
T86	Observation 1088 1102	seroconversión
A5	Assertion T86 Negated
#73	AnnotatorNotes T86	C4042908; Seroconversion; Finding
R52	Negation Arg1:T85 Arg2:T86	
R53	Experiences Arg1:T62 Arg2:T86	
R54	Experiences Arg1:T62 Arg2:T5	
R55	Overlap Arg1:T86 Arg2:T63	
T87	Result_or_Value 1017 1034	valores negativos
#74	AnnotatorNotes T87	valores negativos
R56	Overlap Arg1:T87 Arg2:T63	
R57	Overlap Arg1:T20 Arg2:T63	
R58	Overlap Arg1:T84 Arg2:T63	
R59	Overlap Arg1:T21 Arg2:T63	
T88	Result_or_Value 1139 1147	negativo
#75	AnnotatorNotes T88	C0205160; Negative; Finding
T89	Result_or_Value 1812 1820	negativo
#76	AnnotatorNotes T89	C0205160; Negative; Finding
T90	Result_or_Value 1173 1185	negativizado
#77	AnnotatorNotes T90	C0205160; Negative; Finding
T91	Result_or_Value 1293 1301	negativo
#78	AnnotatorNotes T91	C0205160; Negative; Finding
T92	Result_or_Value 1398 1407	negativos
#79	AnnotatorNotes T92	C0205160; Negative; Finding
R61	Has_Result_or_Value Arg1:T27 Arg2:T92	
R62	Has_Duration_or_Interval Arg1:T26 Arg2:T70	
R63	Experiences Arg1:T66 Arg2:T22	
R65	Experiences Arg1:T66 Arg2:T23	
R66	Experiences Arg1:T68 Arg2:T24	
R67	Experiences Arg1:T68 Arg2:T39	
R69	Experiences Arg1:T68 Arg2:T25	
T93	Result_or_Value 1282 1290	positivo
#80	AnnotatorNotes T93	C1446409; Positive; Finding
R72	Experiences Arg1:T68 Arg2:T26	
T94	Observation 1445 1478	niveles normales de transaminasas
#81	AnnotatorNotes T94	C0580474; AST/SGOT level normal; Finding
R73	Overlap Arg1:T92 Arg2:T94	
T95	Observation 1559 1568	respuesta
#82	AnnotatorNotes T95	C1319171; Medication response; Finding
R74	Experiences Arg1:T75 Arg2:T95	
R75	Overlap Arg1:T95 Arg2:T29	
R76	Experiences Arg1:T75 Arg2:T29	
T96	Observation 1671 1685	seroconversión
R77	Experiences Arg1:T75 Arg2:T96	
R78	Experiences Arg1:T75 Arg2:T10	
#83	AnnotatorNotes T96	C4042908; Seroconversion; Finding
T97	Neg_cue 1649 1656	excepto
A6	Assertion T96 Negated
R79	Negation Arg1:T97 Arg2:T96	
T98	Neg_cue 1724 1728	nula
R80	Negation Arg1:T98 Arg2:T96	
R81	Experiences Arg1:T77 Arg2:T30	
R83	Experiences Arg1:T77 Arg2:T41	
R84	Experiences Arg1:T77 Arg2:T31	
R86	Experiences Arg1:T77 Arg2:T96	
R87	Experiences Arg1:T75 Arg2:T30	
R88	Experiences Arg1:T75 Arg2:T41	
R89	Experiences Arg1:T75 Arg2:T31	
R91	Experiences Arg1:T77 Arg2:T10	
R92	Experiences Arg1:T77 Arg2:T29	
R93	Experiences Arg1:T77 Arg2:T95	
R94	Experiences Arg1:T79 Arg2:T32	
R95	Has_Duration_or_Interval Arg1:T32 Arg2:T80	
R96	Experiences Arg1:T77 Arg2:T32	
R97	Experiences Arg1:T75 Arg2:T32	
R99	Experiences Arg1:T79 Arg2:T31	
R100	Experiences Arg1:T79 Arg2:T41	
R101	Experiences Arg1:T79 Arg2:T30	
R102	Experiences Arg1:T79 Arg2:T10	
R103	Experiences Arg1:T79 Arg2:T96	
R104	Experiences Arg1:T79 Arg2:T29	
R105	Experiences Arg1:T79 Arg2:T95	
R107	Location_of Arg1:T40 Arg2:T57	
R108	Before Arg1:T29 Arg2:T96	
R44	Has_Result_or_Value Arg1:T22 Arg2:T88	
R45	Has_Result_or_Value Arg1:T23 Arg2:T90	
R46	Has_Result_or_Value Arg1:T25 Arg2:T93	
R64	Has_Result_or_Value Arg1:T25 Arg2:T91	
R70	Has_Result_or_Value Arg1:T31 Arg2:T89	
A7	Assertion T81 Negated
R43	Negation Arg1:T60 Arg2:T81	
R71	Has_Result_or_Value Arg1:T18 Arg2:T81	
R60	Has_Result_or_Value Arg1:T20 Arg2:T87	
R85	Experiences Arg1:T62 Arg2:T20	
R98	Has_Result_or_Value Arg1:T21 Arg2:T84	
R90	Overlap Arg1:T64 Arg2:T1	
R106	Overlap Arg1:T67 Arg2:T33	
R109	Overlap Arg1:T65 Arg2:T33	
R110	Experiences Arg1:T49 Arg2:T82	
R68	Experiences Arg1:T73 Arg2:T57	
#84	AnnotatorNotes T63	C0521116; Current (present time); Temporal Concept
A8	Experiencer T79 Patient
A9	Experiencer T44 Patient
A10	Experiencer T47 Patient
A11	Experiencer T49 Patient
A12	Experiencer T50 Patient
A13	Experiencer T56 Patient
A14	Experiencer T59 Patient
A15	Experiencer T61 Patient
A16	Experiencer T62 Patient
A17	Experiencer T66 Patient
A18	Experiencer T68 Patient
A19	Experiencer T73 Patient
A20	Experiencer T75 Patient
A21	Experiencer T77 Patient
R82	Has_Result_or_Value Arg1:T28 Arg2:T94	
